« Promising New Neuroimaging Techniques For Early Detection Of Alzheimer’s Disease: Surprising New Tricks For Old Drugs
One In Five Nursing Homes Receive Poor Quality Ratings, Analysis Finds »

Geron Forms Collaboration To Investigate GRNOPC1 In Alzheimer’s Disease Models

January 30th, 2010 by admin

Zoloft Children Overdose Blood Pressure Meds And Viagra Does Paxil And Dexatrim Max Interact Prednisone Damage Heart Cipro Ear Drops Use In Dogs Medicamento Nexium Can Lamictal Cause Tremors Sulfur Antabuse Is Hgh Sold In Stores Soma Safe Bed Meloxicam Tbts Mobic Augmentin 875-125 Dosage All Natura Viagra Omnicef Induced Fever Pregnancy And Dilantin Transsexual Breast Augmentation Desyrel 50mg Effexor And Relax Ventolin Evohaler Clomid Testicular Axis Allegra Lead Investigator Prednisone High Dose Long Term How Good Is Fosamax Maximum Dose Of Aricept Paxil Lawsuits Delaware Norvasc Adverse Effects Osteoarthritis Paxil Viagra Online Ordering Flomax Generic Name Flonase Leukopenia Dilantin Blood Level Ultram Picture Thunderbird Samaritan Coumadin Clinic Allergic To Prozac Artist Michael Soma Differin Mall Toronto Synthroid And Calcium Statistics Of Weight Gain On Paxil Lexapro Image Breast Enhancement Archive Zocor Pros Cons Conditions Sinequan Can Be Prescribed For Active Ingredients In Motrin Arimidex Men Excess Estrogen Osteoporosis Adhd Lexapro Effexor Prilosec United Kingdom Drug Interactions With Prozac Natural Viagra China Prednisone Azathioprine Weaning Off Of Prozac And Pregnancy

Geron Corporation (Nasdaq:GERN) announced that it has entered into a collaboration jointly funded by Geron and a University of California Discovery Research and Training Grant to investigate the therapeutic potential of its human embryonic stem cell (hESC)-based product, GRNOPC1, for Alzheimer’s disease. The company is currently developing GRNOPC1 for the potential treatment of spinal cord injury…

More: continued here
Powered by SmartRSS

This entry was posted on Saturday, January 30th, 2010 at 6:01 pm and is filed under Alzheimer's Disease. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply